Argent Biopharma Limited has released a press release.
85% Increase in Order Volume of New Prescription Products
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Security Purchase Plan- Offer Document
- MGC Pharma announces $1m Strategic Placement and $3m SPP
- Agreement Signed with Leading Peruvian Distributor
- Supply Agreement with THC Global for Canndeo Products
- MGC Pharma Crosses 2,000 Prescription Milestone
Later from Argent Biopharma
- Commercial Supply Deal Signed for First Products into Poland
- Binding Amendment to Supply Agreement with ONIX Brazil
- Patients Begin Treatment in Clinical Trial of CogniCann
- MGC Pharma COVID-19 Business and Operations Update
- MGC Pharma Signs Agreement Targeting Anti-Viral Treatments
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma